These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1651686)

  • 21. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination of transcatheter arterial infusion of SMANCS and embolization on hepatocellular carcinoma].
    Hirashima N; Kumada K; Sakakibara K; Hirai T; Nemoto S; Matsuura H; Itazu I; Nojiri O; Kano H
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1411-5. PubMed ID: 7668880
    [No Abstract]   [Full Text] [Related]  

  • 24. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
    Okusaka T; Okada S; Ishii H; Ikeda M; Nakasuka H; Nagahama H; Iwata R; Furukawa H; Takayasu K; Nakanishi Y; Sakamoto M; Hirohashi S; Yoshimori M
    Oncology; 1998; 55(4):276-83. PubMed ID: 9663415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intra-arterial injection of an oily antineoplastic agent in hepatic cancer].
    Konno T; Tashiro S; Maeda H; Iwai K; Ogata K; Mochinaga M; Uemura K; Ishimaru S; Miyauchi Y; Yokoyama I
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):351-7. PubMed ID: 6309086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
    Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
    J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can we avert hepatic vascular complications in SMANCS therapy for hepatocellular carcinoma?
    Okada S
    J Gastroenterol; 2000; 35(5):407-9. PubMed ID: 10832680
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma.
    Seymour LW; Olliff SP; Poole CJ; De Takats PG; Orme R; Ferry DR; Maeda H; Konno T; Kerr DJ
    Int J Oncol; 1998 Jun; 12(6):1217-23. PubMed ID: 9592177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma].
    Matoba M; Okimura T; Yamamoto I
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
    Maki S; Konno T; Iwai K; Uchida M; Tashiro S; Miyauchi Y; Maeda H
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1443-9. PubMed ID: 6097616
    [No Abstract]   [Full Text] [Related]  

  • 32. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y; Nakamura H
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma].
    Ihaya T; Ametani M; Matsusue E
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI].
    Shimizu T; Endou H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.
    Tashiro S; Maeda H
    Jpn J Med; 1985 Feb; 24(1):79-80. PubMed ID: 2987585
    [No Abstract]   [Full Text] [Related]  

  • 36. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].
    Kubo M; Fuchigami T; Murata S; Konno T; Maeda H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of hepatocellular carcinoma with tumor thrombus in the right atrium successfully treated by arterial administration of lipiodol-SMANCS].
    Yamada K; Sato T; Yamada A; Tanaka S; Fujii S; Matuo R; Murata K; Manabe T; Oda J
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):361-4. PubMed ID: 10065101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.